28 April 2015 – Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, predicts a substantial increase in device integration in clinical trials and real world programs in 2015 and beyond. Device integration has proved highly beneficial, in part because it creates a simple interface for medical device readings which are a fundamental part of electronic clinical outcomes assessment (eCOA) data. Additionally, there is a clear market trend to design solutions fully compatible with a multitude of home monitoring devices, all of which are capable of being integrated into eDiaries, via Bluetooth® or Near Field Communication, ensuring on-time and highly accurate recording of outcomes. As a consequence, demand for device integration is rising fast.
The growing use of ePRO data collection, combined with Bluetooth® technology being built into many devices, is fast enabling the integration of medical device readings into regular ePRO collection by patients, both in clinical trials and in healthcare settings. Device integration goes far beyond just medical devices though, with a growing market trend fast evolving to utilize and integrate consumer technology (ranging from weighting scales, thermometers and activity trackers) as tools to collect secondary outcomes data. Whilst class I or above medical devices are recommended for primary endpoints, especially in phase IIIa studies, a broad range of medical and consumer technologies are finding application in secondary endpoints across all phases due to the valuable insight they provide into physiological data and patient well-being.
Device integration has multiple benefits. This includes real-time data review, time and cost saving in large projects and ease of use for patients, especially those with mobility issues who no longer have to travel to see HCPs. Moreover, device integration solves the serious problem of data collected through different instruments – in which patients often can report incorrect or subjective information on their well-being and their results. The real-time collection of data removes the need to rely on patients for accurate reporting and delivers objective information. Tim Davis, CEO of Exco InTouch commented: “Device integration has marked itself out as a highly advantageous innovation that is bringing a range of benefits to patients and HCPs alike. Over the past two years we have seen a trend in incorporation of devices to provide valuable supporting data during both clinical trials and healthcare programs. Device integration has proved its worth as a user friendly asset for improving the accuracy, reliability and quality of patient data and reported outcomes.”
Notes to the Editors
How Device Integration works
Data is received via Bluetooth® from diagnostic monitoring devices, such as spirometers, ECGs and blood pressure monitors. The data from these measurement devices is transferred automatically via Bluetooth® to ensure no transcription errors and complete data integrity, with date and time stamps, as well as a full audit trail. Assessment responses and medical device measurements are transmitted automatically to the central database by the software application installed on a mobile phone or tablet device. This takes place immediately on completion of the assessment or, if there is limited network availability, when network connection is resumed.
About Exco InTouch
Exco InTouch is the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers. Using a combination of software and services, Exco InTouch solutions provide simple, secure channels of communication; facilitating the collection of quality data and improving outcomes for sponsors, clinical research organizations, sites and patients.
Working across clinical and late phase trials and mHealth programs, Exco InTouch’s device independent approach enables involvement which integrates into daily life - resulting in motivated and compliant patients, reducing costs associated with withdrawals from trials and improving overall program results.
Since 2004, Exco InTouch has engaged with over 1 million patients across 97 countries, over 26,000 hospitals and clinics, in 70 languages. 16 of the top 20 pharmaceutical companies have deployed our trusted applications in the knowledge that data is secure and protected, in line with global regulatory and data protection requirements.
For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 203 6740 or e-mail: t.jervis@defacto.com
Help employers find you! Check out all the jobs and post your resume.
